Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT00160134
Eligibility Criteria:
Inclusion Criteria:
* history of chronic, symptomatic, mild to severe (NYHA Class II-IV) CHF for at least three months requiring treatment with diuretics and with documented systolic dysfunction
* on stable doses of their individually optimized medication regimen for at least one week prior to enrollment
Exclusion Criteria:
* required hospitalization (for cardiovascular disease) or adjustment of background medications for CHF
* orthostatic hypotension or symptomatic orthostasis
* sitting systolic or diastolic blood pressure \< 90 mmHg
* 2nd or 3rd degree atrio-ventricular block or sick sinus syndrome
* heart rate of \< 50 or \> 110 bpm on the ECG
* transplanted heart
* heart failure due to primary valvular disease (unless surgically corrected), obstructive cardiomyopathy, pericardial disease, cor pulmonale or congenital heart disease
* hemodynamically significant left ventricular outflow tract obstruction
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00160134
Study Brief:
Protocol Section:
NCT00160134